Accelerated Approvals in Oncology (1992 – Present)

Using publicly available data from review documents on Drugs@FDA and information listed in FDA’s public database on post-market requirements (PMRs) Friends created this dashboard to highlight data on original and supplemental Accelerated Approvals in oncology since 1992. 

The dashboard can be used to gain insights on the status of Accelerated Approvals, progress made on fulfilling post-market requirements and commitments under Accelerated Approval, as well as details on the endpoints serving as the basis for granting these approvals.

Last Updated: August 1, 2021.